Page last updated: 2024-11-07

thyroxine and B-Cell Chronic Lymphocytic Leukemia

thyroxine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Research Excerpts

ExcerptRelevanceReference
"In conclusion, low T3 syndrome may be a good candidate for predicting prognosis in future clinical practice of CLL."1.48Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia. ( Chen, RZ; Fan, L; Gao, R; Li, JY; Liang, JH; Wang, L; Xia, Y; Xu, W; Yang, T; Zhu Wu, J; Zhu, HY, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, R1
Chen, RZ1
Xia, Y1
Liang, JH1
Wang, L1
Zhu, HY1
Zhu Wu, J1
Fan, L1
Li, JY1
Yang, T1
Xu, W1

Other Studies

1 other study available for thyroxine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia.
    International journal of cancer, 2018, 08-01, Volume: 143, Issue:3

    Topics: Aged; Aged, 80 and over; Biomarkers; Euthyroid Sick Syndromes; Female; Follow-Up Studies; Humans; Ka

2018